Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

NAFLD in normal weight individuals
Johanna K. DiStefano, Glenn S. Gerhard
Diabetology & Metabolic Syndrome (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Mechanisms Linking Metabolic-Associated Fatty Liver Disease (MAFLD) to Cardiovascular Disease
Olufunto O. Badmus, Terry D. Hinds, David E. Stec
Current Hypertension Reports (2023) Vol. 25, Iss. 8, pp. 151-162
Open Access | Times Cited: 37
Non-Alcoholic Fatty Liver Disease or Type 2 Diabetes Mellitus—The Chicken or the Egg Dilemma
Marcin Kosmalski, Agnieszka Śliwińska, Józef Drzewoski
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1097-1097
Open Access | Times Cited: 25
Exploring the role of genetic variations in NAFLD: implications for disease pathogenesis and precision medicine approaches
Seyedeh Kosar Mahmoudi, Shadi Tarzemani, Taha Aghajanzadeh, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 11
Prevalence of Nonalcoholic Fatty Liver Disease among Obese Patients Presented in Liaquat University Hospital Hyderabad/Jamshoro
Yasra Memon, Ghulam Fareed, Tariq Zaffar Shaikh, et al.
Pakistan Journal of Health Sciences (2025), pp. 249-253
Closed Access
The efficacy of sodium-glucose transporter 2 inhibitors in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis
Hongsheng Li, Yanli Hou, Xin Wang, et al.
Pharmacological Research (2025) Vol. 213, pp. 107647-107647
Open Access
The Role of the Fatty Liver Index (FLI) in the Management of Non-Alcoholic Fatty Liver Disease: A Systematic Review
Teodora Biciusca, Sorina Ionelia Stan, Mara Amalia Bălteanu, et al.
Diagnostics (2023) Vol. 13, Iss. 21, pp. 3316-3316
Open Access | Times Cited: 14
Diet, exercise, and supplements: what is their role in the management of the metabolic dysfunction-associated steatotic liver disease in children?
Anastasios Serbis, Stergios A. Pοlyzos, Stavroula Α. Paschou, et al.
Endocrine (2024) Vol. 85, Iss. 3, pp. 988-1006
Open Access | Times Cited: 4
Non-alcoholic fatty liver disease (NAFLD) and mental illness: Mechanisms linking mood, metabolism and medicines
Anwesha Gangopadhyay, Radwa Ibrahim, Karli Theberge, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 20
Metabolomics to identify fingerprints of carotid atherosclerosis in nonobese metabolic dysfunction-associated fatty liver disease
Congxiang Shao, Lishu Xu, Pingguang Lei, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 8
From adiposity to steatosis: metabolic dysfunction-associated steatotic liver disease, a hepatic expression of metabolic syndrome – current insights and future directions
Bruno Basil, B. Myke-Mbata, Onyinye Ezinne Eze, et al.
Clinical Diabetes and Endocrinology (2024) Vol. 10, Iss. 1
Closed Access | Times Cited: 2
Association between Mediterranean Diet and Fatty Liver in Women with Overweight and Obesity
Alessandro Leone, Simona Bertoli, Giorgio Bedogni, et al.
Nutrients (2022) Vol. 14, Iss. 18, pp. 3771-3771
Open Access | Times Cited: 12
Nutritional Support for Liver Diseases
Dominika Jamioł-Milc, Anna Gudan, Karolina Kaźmierczak-Siedlecka, et al.
Nutrients (2023) Vol. 15, Iss. 16, pp. 3640-3640
Open Access | Times Cited: 6
Diet-induced induction of hepatic serine/threonine kinase STK38 triggers proinflammation and hepatic lipid accumulation
Priya Rawat, Shilpa Thakur, Surbhi Dogra, et al.
Journal of Biological Chemistry (2023) Vol. 299, Iss. 5, pp. 104678-104678
Open Access | Times Cited: 5
Mortality, Hepatic Decompensation, and Cardiovascular- and Renal-Related Outcomes in Lean Versus Non-lean Patients Hospitalized With Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Chukwunonso Ezeani, Chidiebele Omaliko, Yazan A. Al‐Ajlouni, et al.
Cureus (2024)
Open Access | Times Cited: 1
Predictive Value of the Chinese Visceral Adiposity Index for Metabolic Dysfunction-Associated Fatty Liver Disease and Elevated Alanine Aminotransferase Levels in Nonobese Chinese Adults: A Cross-Sectional Study
Zuohu Niu, Jialiang Chen, Huijing Wang, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 3893-3913
Open Access | Times Cited: 1
Association between life’s essential 8 and metabolic dysfunction-associated steatotic liver disease among US adults
Zheng Wang, Bohan Huang, Yixuan Ding, et al.
Archives of Public Health (2024) Vol. 82, Iss. 1
Open Access | Times Cited: 1
Clinical and molecular characterization of steatotic liver disease in the setting of immune-mediated inflammatory diseases
Enrique García-Nieto, Juan Carlos Rodriguez‐Duque, Coral Rivas‐Rivas, et al.
JHEP Reports (2024) Vol. 6, Iss. 10, pp. 101167-101167
Open Access | Times Cited: 1
Lean metabolic dysfunction-associated steatotic disease is reversed by betulinic acid, a therapeutic triterpene from birch bark
Hyun Kyung Kim, Do‐Young Kim, Sumin Kang, et al.
Food Bioscience (2024), pp. 104376-104376
Closed Access | Times Cited: 1
The liver–brain axis in metabolic dysfunction-associated steatotic liver disease
Anne Catrine Daugaard Mikkelsen, Kristoffer Kjærgaard, Anthony H.V. Schapira, et al.
˜The œLancet. Gastroenterology & hepatology (2024)
Closed Access | Times Cited: 1
Risk Prevention and Health Promotion for Non-Alcoholic Fatty Liver Diseases (NAFLD)
Adnan Khan, Heather M. Ross, Natalia Salinas Parra, et al.
Livers (2022) Vol. 2, Iss. 4, pp. 264-282
Open Access | Times Cited: 7
Metabolic dysfunction and nonalcoholic fatty liver disease risk in individuals with a normal body mass index
Johanna K. DiStefano, Glenn S. Gerhard
Current Opinion in Gastroenterology (2023) Vol. 39, Iss. 3, pp. 156-162
Closed Access | Times Cited: 3
Perfluorooctanoic Acid (PFOA) Exposure and Abnormal Alanine Aminotransferase: Using Clinical Consensus Cutoffs Compared to Statistical Cutoffs for Abnormal Values
Alan Ducatman, Youran Tan, Brian A. Nadeau, et al.
Toxics (2023) Vol. 11, Iss. 5, pp. 449-449
Open Access | Times Cited: 3
Mechanisms of non-alcoholic fatty liver disease development in normal-weight individuals
Pablo Muriel, Irina Cardoso-Lezama, Eduardo E. Vargas-Pozada, et al.
European Journal of Gastroenterology & Hepatology (2023) Vol. 35, Iss. 5, pp. 521-529
Closed Access | Times Cited: 2
Low–Normal Thyroid Function Is Not Associated with Either Non-Alcoholic Fatty Liver Disease or with Metabolic Dysfunction-Associated Fatty Liver Disease
Julia María Zuarth-Vázquez, Lidia Moreno-Castañeda, Juan Pablo Soriano-Márquez, et al.
Life (2023) Vol. 13, Iss. 4, pp. 1048-1048
Open Access | Times Cited: 2
Metabolic‐associated fatty liver disease is associated with colorectal adenomas in young and older Korean adults
Jiwon Chang, Yoosoo Chang, Yoosun Cho, et al.
Liver International (2023) Vol. 43, Iss. 11, pp. 2548-2559
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top